Departamento de Medicina Preventiva, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR.
Nucleo de Indicadores e Sistemas de Informacao, Hospital Israelita Albert Einstein, Sao Paulo, SP, BR.
Clinics (Sao Paulo). 2021 Jul 16;76:e2781. doi: 10.6061/clinics/2021/e2781. eCollection 2021.
To analyze the use and acquisition of medicines in São Paulo, Brazil, in 2003 and 2015, according to sociodemographic factors, socioeconomic status, and health conditions of the population.
Data were obtained from population health surveys "ISA-Capital". Descriptive analysis, bivariate analysis, and logistic regression models were used to evaluate the use of medicines and coverage by the Brazilian Unified Health System (SUS) according to socioeconomic status and health conditions in two periods: 2003 and 2015.
From 2003 to 2015, the surveys showed an increase in the income and education level of the study population. There was no increase in the prevalence of chronic diseases and use of medicines from 2003 to 2015. The provision of medicines by SUS was higher in 2015 than in 2003, and the coverage by SUS was higher in the population with lower education level and income in both 2003 and 2015.
The use of medicines, mainly for chronic disease control, did not change over the years, and there was an increase in SUS coverage for medicines during 2003-2015 in all population groups, with a greater impact on the lower socioeconomic status population. The programs of the provision of medicines implanted since 2003 had influenced the greater SUS coverage for medicines and in the reduction of inequalities in access to medicines.
根据人口的社会人口因素、社会经济地位和健康状况,分析巴西圣保罗市 2003 年和 2015 年药品的使用和获取情况。
数据来自“ISA-Capital”人口健康调查。采用描述性分析、双变量分析和逻辑回归模型,根据社会经济地位和健康状况,评估 2003 年和 2015 年两个时期药品的使用情况和巴西全民健康覆盖(SUS)的覆盖情况。
从 2003 年到 2015 年,调查显示研究人群的收入和教育水平有所提高。2003 年至 2015 年期间,慢性病的患病率和药物使用量并未增加。SUS 提供的药物在 2015 年高于 2003 年,在教育水平和收入较低的人群中,SUS 的覆盖范围在 2003 年和 2015 年都更高。
多年来,药品的使用(主要用于慢性病控制)并未发生变化,在 2003-2015 年期间,SUS 对药品的覆盖范围在所有人群中都有所增加,对社会经济地位较低的人群影响更大。自 2003 年以来实施的药品供应计划影响了更大的 SUS 药品覆盖范围,并减少了获得药品方面的不平等。